1988
DOI: 10.1097/00004836-198812000-00022
|View full text |Cite
|
Sign up to set email alerts
|

Estrogen-Progesterone Treatment of Osier-Weber-Rendu Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
15
0
1

Year Published

1992
1992
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 44 publications
(16 citation statements)
references
References 0 publications
0
15
0
1
Order By: Relevance
“…Three of them examine the efficacy of drugs related to female sex hormones. Van Cutsem et al successfully treated patients with bleeding angiodysplastic gastrointestinal lesions due to HHT and other medical reasons successfully with estrogens and progesterons [12]. Vase could not confirm an effect of estrogen on hemoglobin nor on epistaxis [13].…”
Section: Discussionmentioning
confidence: 99%
“…Three of them examine the efficacy of drugs related to female sex hormones. Van Cutsem et al successfully treated patients with bleeding angiodysplastic gastrointestinal lesions due to HHT and other medical reasons successfully with estrogens and progesterons [12]. Vase could not confirm an effect of estrogen on hemoglobin nor on epistaxis [13].…”
Section: Discussionmentioning
confidence: 99%
“…Das therapeutische Repertoire der Epistaxis umfasst das Einbringen von Vasokonstriktiva, mechanische Kompression der Nasenflügel, vordere/hintere Nasentamponade, Lasertherapieverfahren, die Dermoplastik nach Saunders (41), Gefäßembolisationen, Gefäßligaturen (12), die Therapie mit Östrogenen (3,47) oder als ultimo ratio einen Verschluss der Nasenhaupthöhle (11). Die Anwendung von fettenden Nasensalben (50) ist grundsätzlich zu empfehlen.…”
Section: Nase/hautunclassified
“…Repeated blood transfusion with iron supplementation to replace the ongoing losses is the only wellaccepted treatment. In some small trials, hormonal therapy with estrogen-progestogen (ethinyloestridiol 0.05 mg and norethisterone 1 mg daily, given orally) combinations has been shown to decrease transfusion requirements in patients with gastrointestinal bleeding [44][45][46][47]. The exact mechanism is not known but a primary effect on coagulation, stasis in the mesenteric circulation, restoration of the endothelium of the abnormal vessels, and inhibition of prostacyclin production and release are among the proposed hypotheses [46][47][48][49][50].…”
Section: Gastrointestinal Involvementmentioning
confidence: 99%